Priser
Platform
Blog
Om os
Download
Cegedim
Cegedim
Euronext Paris

Markedsdata leveret af TwelveData og Morningstar

Aktiemarkedet kan gå både op og ned. Selvom investeringer i aktier historisk set har givet investorer et positivt afkast på langt sigt, er der ingen garanti for fremtidige afkast. Der er derfor en risiko for, at du ikke får de investerede penge tilbage.

INVESTER I CEGEDIM MED ENDAVU: Køb Cegedim ($ALCGM) aktier gennem Endavu’s investeringsplatform. Hos Endavu kan du købe og sælge aktier i Cegedim, og handle med aktier, fraktionaler, ETF'er og andre finansielle instrumenter. Endavu tilbyder handel uden kurtage på amerikanske aktier. Endavu tilbyder lav kurtage på tværs af aktier. Handl med over 30.000 forskellige aktier og udenfor markedsåbningstider.

Om

Cegedim SA is a healthcare technology and services company focused on digital data flow management for healthcare ecosystems and business-to-business operations. Cegedim SA develops software and digital solutions for healthcare professionals, insurance organizations, pharmacies, hospitals, and life sciences companies, supporting functions such as medical information exchange, practice management, claims and administrative processing, payroll and human resources services, and hosted IT solutions. Its portfolio includes tools for online appointment booking and teleconsultation, as well as products for electronic data interchange, customer relationship management, digital promotion, and pharmacy and hospital software. Headquartered in Boulogne-Billancourt, France, Cegedim SA plays a specialized role in the healthcare and insurance markets by helping organizations digitize workflows, manage sensitive information, and connect operational processes across professional networks.

Information

TickerALCGM
Land
Frankrig
Antal medarbejdere6.200
Hjemmesidecegedim.com
SektorSundhed
IndustriSundhedsinformationstjenester

Udbytter

0,66EUR
'06
0,68EUR
'07
0,77EUR
'08
1EUR
'10
1EUR
'11
0,5EUR
'22
Ex-udbytte-dato29. jun. 2022
Udbytteafkast0%

Analytikerskøn

Baseret på 2 analytikere

Stærkt købKøbHoldSælgStærkt sælg
0%50%50%0%0%